Agios to Webcast Conference Call of Second Quarter 2023 Financial Results on Aug. 3, 2023
13 Julho 2023 - 8:00AM
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the field
of cellular metabolism pioneering therapies for rare diseases,
today announced the company will host a conference call and live
webcast on Thursday, Aug. 3, 2023, at 8:00 a.m. ET to report its
second quarter 2023 financial results and other business
highlights.
A live webcast of the presentation can be accessed under "Events
& Presentations" in the Investors section of the company's
website at www.agios.com. A replay of the webcast will be archived
on the company’s website for at least two weeks following the
presentation.
About AgiosAgios is the pioneering leader in PK
activation and is dedicated to developing and delivering
transformative therapies for patients living with rare diseases. In
the U.S., Agios markets a first-in-class pyruvate kinase (PK)
activator for adults with PK deficiency, the first
disease-modifying therapy for this rare, lifelong, debilitating
hemolytic anemia. Building on the company's leadership in the field
of cellular metabolism, Agios is advancing a robust clinical
pipeline of investigational medicines with programs in alpha- and
beta-thalassemia, sickle cell disease, pediatric PK deficiency and
MDS-associated anemia. In addition to its clinical pipeline, Agios
has a PAH stabilizer in preclinical development as a potential
treatment for phenylketonuria (PKU) and deep scientific expertise
in classical hematology. For more information, please visit the
company’s website at www.agios.com.
Contacts:
Investor ContactChris Taylor, VP, Investor
Relations and Corporate CommunicationsAgios
PharmaceuticalsIR@agios.com
Media Contact Dan Budwick1AB Media
dan@1abmedia.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024